The Rise of Colorectal Cancer in Younger People and Updated Screening Guidelines
Release Date: 05/15/2024
Navigating Holiday Challenges: Dr. Muenks Answers Questions from Our Listeners
Bench to Bedside
In this special mini episode of the Bench to Bedside Podcast, Dr. Elizabeth Muenks, director of The University of Kansas Cancer Center's Onco-Psychology Program, addresses listener-submitted questions on managing the holiday season while navigating a loved one's cancer journey. The episode provides thoughtful advice on keeping loved ones involved without overwhelming them, adjusting holiday traditions to accommodate dietary restrictions and energy levels, and balancing caregiving responsibilities with holiday preparations. In this conversation, Dr. Muenks emphasizes the value of open...
info_outline
MyeloMATCH: The New Front in the Battle Against Leukemia
Bench to Bedside
In this episode of the Bench to Bedside Podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, discusses exciting advancements in the treatment of acute myeloid leukemia (AML) with Dr. Tara Lin, director of the adult leukemia program at KU Cancer Center and site principal investigator for myeloMATCH (Myeloid Malignancies Molecular Analysis for Therapy Choice), a precision-medicine initiative sponsored by the National Cancer Institute (NCI). MyeloMATCH is an “umbrella trial,” a group of clinical substudies for people with acute myeloid leukemia or...
info_outline
Strength in Love: Navigating the Journey as a Cancer Caregiver
Bench to Bedside
In this poignant episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, speaks with Cheryl Jernigan, Lead Patient Research Advocate with Patient and Investigator Voices Organizing Together (PIVOT). Cheryl shares her powerful story of being both a cancer survivor herself and a co-survivor and caregiver to her husband, who battled both prostate cancer and tonsil cancer caused by human papillomavirus (HPV). Their discussion explores the emotional and physical challenges of caregiving, the importance of research and patient...
info_outline
Investigating the Link Between Obesity and Cancer
Bench to Bedside
Being overweight or having obesity is linked with a higher risk of getting 13 types of cancer. These cancers comprise 40% of all cancers diagnosed in the United States each year. In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, speaks with Dr. John Thyfault, professor in the Department of Cell Biology and Physiology and in the Division of Endocrinology, Metabolism and Genetics, as well as director of the University of Kansas Diabetes Institute and co-leader of the Kansas Center for Metabolism and Obesity...
info_outline
Empowering the Future Leaders of Clinical Research with KU Cancer Center’s C-CLEAR Program
Bench to Bedside
In this episode of the Bench to Bedside podcast Joseph Hines, II, MPH, senior director of research operations at The University of Kansas Cancer Center, joins Dr. Roy Jensen, vice chancellor and director, to discuss the launch and success of the CAREERS in CLINICAL RESEARCH PROGRAM (C-CLEAR Program). This groundbreaking initiative is designed to introduce college students in the region to the dynamic and impactful field of clinical research. Hines, along with students Mariah Slaughter, Hilary Tallman, and Angel Tchamnou, share their experiences and the program's impact on their understanding...
info_outline
Brain Health and Cancer: Addressing Cancer Related Cognitive Changes
Bench to Bedside
In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer center, speaks with Dr. Jamie Myers, an advanced practice oncology nurse with more than 40 years of experience and Research Associate Professor at the University of Kansas Medical Center’s School of Nursing. Dr. Myers’ research is focused on cognitive changes related to cancer and cancer treatment therapy. In this conversation, she shares more about this topic - often referred to as “chemo brain” – and how these cognitive changes affect memory,...
info_outline
Unveiling the Mysteries of Ovarian Cancer: The Cancer that Whispers
Bench to Bedside
In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer center, speaks with Dr. Diane Mahoney, assistant professor in the School of Nursing at the University of Kansas Medical Center and member of KU Cancer Center’s Cancer Prevention and Control research program, about ovarian cancer, a disease often diagnosed at an advanced stage due to nonspecific symptoms. Dr. Mahoney discusses the importance of early detection, current treatment options and her promising research into the human microbiome's role in ovarian cancer....
info_outline
Innovations in Radiation Oncology
Bench to Bedside
Approaching cancer from unique angles and perspectives is crucial for gaining an understanding of this disease and optimizing treatment strategies for patients. In the Department of Radiation Oncology at The University of Kansas Cancer Center, our specialists work to accelerate progress toward more personalized and effective ways to treat cancer through research and clinical trials. In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, speaks with Dr. Xinglei Shen, associate professor in the Department of...
info_outline
Exploring the Future of Cancer Care: What is Tumor-Infiltrating Lymphocyte (TIL) Therapy?
Bench to Bedside
Immunotherapy and cellular therapeutics represent the future of cancer care. These biological therapies involve manipulating the body’s cells to reactivate and strengthen their abilities to attack cancer cells. Immunotherapy is a precision cancer treatment and is considered the future of cancer treatment by the National Cancer Institute. Other, more traditional, types of cancer treatment include surgery, chemotherapy and radiation. Immunotherapy is a type of treatment for a variety of cancers that harnesses one’s own immune system to fight his or her specific cancer cells. Tumor...
info_outline
The Rise of Colorectal Cancer in Younger People and Updated Screening Guidelines
Bench to Bedside
Colorectal cancer, also called colon cancer or rectal cancer, is one of the most treatable cancers when found early. However, it is also the most common type of gastrointestinal cancer and is the second leading cause of cancer deaths in the United States. For decades, colorectal cancer was most often diagnosed in people aged 50 and over. More recently, the incidence of colorectal cancer has declined in people 50 and over, while dramatically increasing in younger people. Because of this shift, the American Cancer Society recently revised its colorectal cancer screening guidelines for people at...
info_outlineColorectal cancer, also called colon cancer or rectal cancer, is one of the most treatable cancers when found early. However, it is also the most common type of gastrointestinal cancer and is the second leading cause of cancer deaths in the United States. For decades, colorectal cancer was most often diagnosed in people aged 50 and over. More recently, the incidence of colorectal cancer has declined in people 50 and over, while dramatically increasing in younger people. Because of this shift, the American Cancer Society recently revised its colorectal cancer screening guidelines for people at average risk. According to the updated guidelines, individuals at average risk of colorectal cancer should have regular screening for colon cancer beginning at age 45. On this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, discusses this topic with Dr. John Ashcraft, Associate Professor of Surgery and Division Chief of the Colorectal & Oncologic Surgery Division at the University of Kansas Medical Center, and Dr. Raed Al-Rajabi, Associate Professor of medicine in the division of medical oncology and leader of the gastrointestinal medical oncology group at the University of Kansas Medical Center.
Links from this Episode:
-
Read the new American Cancer Society guidelines for colon cancer screening
-
Learn more about colon cancer screening and treatment at KU Cancer Center
-
Read about Dr. Ajay Bansal’s Lynch Syndrome research and clinic
-
Learn more about Dr. John Ashcraft and Dr. Raed Al-Rajabi
After listening to this episode, we invite YOU to be a part of the podcast! We want to hear your thoughts on the conversations we have here, topics you’d like to learn more about and any questions you may have for our guests. Call our Bench to Bedside hotline at 913-588-3880 and leave us a voicemail, or you can email your comments and questions to [email protected]. Your comments may be shared on a future episode!